LTR Pharma (ASX:LTP) Other Operating Expense: A$1.00 Mil (TTM As of Dec. 2025)


ASX:LTP LTR Pharma Ltd ASX:LTP
15 GF Score
Price A$0.57
! 1 Warning Sign
View Full Analysis

What is LTR Pharma Other Operating Expense?

LTR Pharma ASX:LTP -5.22% 15 Other Operating Expense is A$1.00 Mil as of Dec. 2025. GuruFocus rates ASX:LTP with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

LTR Pharma's Other Operating Expense for the six months ended in Dec. 2025 was A$0.45 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$1.00 Mil.

LTR Pharma's quarterly Other Operating Expense declined from Dec. 2024 (A$0.59 Mil) to Jun. 2025 (A$0.55 Mil) and declined from Jun. 2025 (A$0.55 Mil) to Dec. 2025 (A$0.45 Mil).

LTR Pharma's annual Other Operating Expense increased from Jun. 2023 (A$0.16 Mil) to Jun. 2024 (A$1.20 Mil) but then declined from Jun. 2024 (A$1.20 Mil) to Jun. 2025 (A$1.13 Mil).

LTR Pharma Other Operating Expense Historical Data

* Premium members only.

The historical data trend for LTR Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LTR Pharma Other Operating Expense Chart

LTR Pharma Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Other Operating Expense
0.03 0.28 0.16 1.20 1.13

LTR Pharma Semi-Annual Data
Jun21 Jun22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Operating Expense Get a 7-Day Free Trial 0.58 0.62 0.59 0.55 0.45
ASX:LTP
15GF Score
LTR Pharma Ltd ASX:LTP
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LTR Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$1.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of A$1.00 Mil mean?
LTR Pharma (ASX:LTP) has a Other Operating Expense of A$1.00 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on LTR Pharma and its competitors.
Is LTR Pharma's Other Operating Expense too high?
LTR Pharma's current Other Operating Expense is A$1.00 Mil. Overall, LTR Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does LTR Pharma's Other Operating Expense compare to VRTX and REGN?
LTR Pharma's Other Operating Expense of A$1.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on LTR Pharma and its competitors. LTR Pharma's current Other Operating Expense is A$1.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LTR Pharma stock overvalued right now?
LTR Pharma (ASX:LTP) has a current Other Operating Expense of A$1.00 Mil. The current Other Operating Expense is A$1.00 Mil. LTR Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For LTR Pharma (ASX:LTP), the current Other Operating Expense is A$1.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LTR Pharma Business Description

Address 9A/204 Alice Street, Brisbane, QLD, AUS, 4000
LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on the market.
15GF Score

Get the complete analysis for ASX:LTP

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.57
Price